Free Trial

Venture Life Group (VLG) Competitors

Venture Life Group logo
GBX 40.80 -0.20 (-0.49%)
As of 03/28/2025 12:16 PM Eastern

VLG vs. ANCR, DNL, EAH, STX, PXS, CHLL, MXC, RGT, CEL, and N4P

Should you be buying Venture Life Group stock or one of its competitors? The main competitors of Venture Life Group include Animalcare Group (ANCR), Diurnal Group (DNL), ECO Animal Health Group (EAH), Shield Therapeutics (STX), Provexis (PXS), Chill Brands Group (CHLL), Argent BioPharma (MXC), Argent BioPharma (RGT), Celadon Pharmaceuticals (CEL), and N4 Pharma (N4P). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Venture Life Group vs.

Animalcare Group (LON:ANCR) and Venture Life Group (LON:VLG) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, community ranking, profitability, earnings, risk, media sentiment, institutional ownership and valuation.

Animalcare Group has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500. Comparatively, Venture Life Group has a beta of 0.3, suggesting that its share price is 70% less volatile than the S&P 500.

Animalcare Group has higher revenue and earnings than Venture Life Group. Animalcare Group is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Animalcare Group£84.90M1.77£36.55M£53.644.08
Venture Life Group£51.77M1.00£747.21K£0.5969.24

49.0% of Animalcare Group shares are owned by institutional investors. Comparatively, 69.5% of Venture Life Group shares are owned by institutional investors. 29.5% of Animalcare Group shares are owned by company insiders. Comparatively, 10.4% of Venture Life Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Venture Life Group had 1 more articles in the media than Animalcare Group. MarketBeat recorded 1 mentions for Venture Life Group and 0 mentions for Animalcare Group. Animalcare Group's average media sentiment score of 0.00 equaled Venture Life Group'saverage media sentiment score.

Company Overall Sentiment
Animalcare Group Neutral
Venture Life Group Neutral

Animalcare Group has a net margin of 43.05% compared to Venture Life Group's net margin of 1.44%. Animalcare Group's return on equity of 36.62% beat Venture Life Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Animalcare Group43.05% 36.62% 2.97%
Venture Life Group 1.44%0.99%1.56%

Venture Life Group received 2 more outperform votes than Animalcare Group when rated by MarketBeat users. Likewise, 72.90% of users gave Venture Life Group an outperform vote while only 69.37% of users gave Animalcare Group an outperform vote.

CompanyUnderperformOutperform
Animalcare GroupOutperform Votes
154
69.37%
Underperform Votes
68
30.63%
Venture Life GroupOutperform Votes
156
72.90%
Underperform Votes
58
27.10%

Summary

Animalcare Group beats Venture Life Group on 9 of the 14 factors compared between the two stocks.

Remove Ads
Get Venture Life Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for VLG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VLG vs. The Competition

MetricVenture Life GroupDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£51.99M£2.27B£5.63B£2.61B
Dividend Yield0.09%2.92%5.33%4.82%
P/E Ratio69.244.2823.55141.21
Price / Sales1.00575.41388.19284,066.48
Price / Cash6.4010.2538.1728.12
Price / Book0.696.556.894.63
Net Income£747,207.14£20.70B£3.20B£5.82B
7 Day Performance-0.49%-2.72%-3.06%1.44%
1 Month Performance0.74%-2.95%1.51%7.39%
1 Year Performance11.02%92.65%9.35%112.67%

Venture Life Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VLG
Venture Life Group
N/AGBX 40.80
-0.5%
N/A+11.0%£51.99M£51.77M69.24165
ANCR
Animalcare Group
N/AGBX 218.26
-0.3%
N/A+4.1%£149.64M£84.90M4.07220
DNL
Diurnal Group
N/AN/AN/AN/A£46.33M£4.68M-3.2133
EAH
ECO Animal Health Group
N/AGBX 57.66
-1.4%
N/A-34.5%£39.07M£89.44M37.27234High Trading Volume
STX
Shield Therapeutics
N/AGBX 3.01
-1.3%
N/A+48.1%£29.71M£20.92M-0.7840,000Gap Down
PXS
Provexis
N/AGBX 0.48
-1.4%
N/A-20.5%£11.33M£846,984.38-18.314
CHLL
Chill Brands Group
N/AN/AN/AN/A£10.89M£624,187.00-215.007
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32M-13.255Gap Up
RGT
Argent BioPharma
N/AN/AN/AN/A£8.31MN/A-0.65N/AGap Down
High Trading Volume
CEL
Celadon Pharmaceuticals
N/AGBX 13.24
-1.9%
N/A-89.6%£8.12M£123,381.65-1.662,780Gap Down
High Trading Volume
N4P
N4 Pharma
N/AGBX 0.45
-5.1%
N/A-27.8%£1.94M£8,841.37-1.305
Remove Ads

Related Companies and Tools


This page (LON:VLG) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners